Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid?Based Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid?Based Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid?Based Diagnostic Overall Market Size
2.1 Global Nucleic Acid?Based Diagnostic Market Size: 2022 VS 2030
2.2 Global Nucleic Acid?Based Diagnostic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nucleic Acid?Based Diagnostic Players in Global Market
3.2 Top Global Nucleic Acid?Based Diagnostic Companies Ranked by Revenue
3.3 Global Nucleic Acid?Based Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid?Based Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nucleic Acid?Based Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid?Based Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Nucleic Acid?Based Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid?Based Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nucleic Acid?Based Diagnostic Market Size Markets, 2022 & 2030
4.1.2 Nucleic Acid Molecular Hybridization
4.1.3 Polymerase Chain Reaction
4.1.4 Thermostatic Amplification
4.1.5 Gene Sequencing
4.1.6 Biochip Technology
4.2 By Type - Global Nucleic Acid?Based Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Nucleic Acid?Based Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Nucleic Acid?Based Diagnostic Revenue, 2024-2030
4.2.3 By Type - Global Nucleic Acid?Based Diagnostic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nucleic Acid?Based Diagnostic Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinical Laboratory
5.1.4 Research Institutions
5.1.5 Clinic
5.1.6 Other
5.2 By Application - Global Nucleic Acid?Based Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Nucleic Acid?Based Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Nucleic Acid?Based Diagnostic Revenue, 2024-2030
5.2.3 By Application - Global Nucleic Acid?Based Diagnostic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Nucleic Acid?Based Diagnostic Market Size, 2022 & 2030
6.2 By Region - Global Nucleic Acid?Based Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Nucleic Acid?Based Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Nucleic Acid?Based Diagnostic Revenue, 2024-2030
6.2.3 By Region - Global Nucleic Acid?Based Diagnostic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Nucleic Acid?Based Diagnostic Revenue, 2018-2030
6.3.2 US Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.3.3 Canada Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.3.4 Mexico Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Nucleic Acid?Based Diagnostic Revenue, 2018-2030
6.4.2 Germany Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.3 France Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.4 U.K. Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.5 Italy Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.6 Russia Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.7 Nordic Countries Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.4.8 Benelux Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Nucleic Acid?Based Diagnostic Revenue, 2018-2030
6.5.2 China Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.5.3 Japan Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.5.4 South Korea Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.5.5 Southeast Asia Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.5.6 India Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Nucleic Acid?Based Diagnostic Revenue, 2018-2030
6.6.2 Brazil Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.6.3 Argentina Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nucleic Acid?Based Diagnostic Revenue, 2018-2030
6.7.2 Turkey Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.7.3 Israel Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.7.4 Saudi Arabia Nucleic Acid?Based Diagnostic Market Size, 2018-2030
6.7.5 UAE Nucleic Acid?Based Diagnostic Market Size, 2018-2030
7 Nucleic Acid?Based Diagnostic Companies Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Nucleic Acid?Based Diagnostic Major Product Offerings
7.1.4 Agilent Technologies Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Agilent Technologies Key News & Latest Developments
7.2 Danaher Corporation
7.2.1 Danaher Corporation Company Summary
7.2.2 Danaher Corporation Business Overview
7.2.3 Danaher Corporation Nucleic Acid?Based Diagnostic Major Product Offerings
7.2.4 Danaher Corporation Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Danaher Corporation Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Nucleic Acid?Based Diagnostic Major Product Offerings
7.3.4 Abbott Laboratories Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 BD
7.4.1 BD Company Summary
7.4.2 BD Business Overview
7.4.3 BD Nucleic Acid?Based Diagnostic Major Product Offerings
7.4.4 BD Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.4.5 BD Key News & Latest Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Summary
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Nucleic Acid?Based Diagnostic Major Product Offerings
7.5.4 Bio-Rad Laboratories Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Bio-Rad Laboratories Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Nucleic Acid?Based Diagnostic Major Product Offerings
7.6.4 Roche Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Illumina, Inc
7.7.1 Illumina, Inc Company Summary
7.7.2 Illumina, Inc Business Overview
7.7.3 Illumina, Inc Nucleic Acid?Based Diagnostic Major Product Offerings
7.7.4 Illumina, Inc Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Illumina, Inc Key News & Latest Developments
7.8 Thermo Fisher Scientific Inc.
7.8.1 Thermo Fisher Scientific Inc. Company Summary
7.8.2 Thermo Fisher Scientific Inc. Business Overview
7.8.3 Thermo Fisher Scientific Inc. Nucleic Acid?Based Diagnostic Major Product Offerings
7.8.4 Thermo Fisher Scientific Inc. Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Nucleic Acid?Based Diagnostic Major Product Offerings
7.9.4 Merck KGaA Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Merck KGaA Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Nucleic Acid?Based Diagnostic Major Product Offerings
7.10.4 Qiagen Nucleic Acid?Based Diagnostic Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer